✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Medicamen Organics Ltd.

MEDIORG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹29 Cr.
P/E
7.29

Medicamen Organics Ltd.

  • Medicamen Organics
  • Omkar Pharmachem
  • Panjon

FAQs on Medicamen Organics Ltd. Shareprice

Medicamen Organics has given lower returns compared to its competitors.
Medicamen Organics has grown at ~-58.38% over the last 1yrs while peers have grown at a median rate of -37.92%

Medicamen Organics is not expensive.
Latest PE of Medicamen Organics is 7.4, while 3 year average PE is 21.49.
Also latest EV/EBITDA of Medicamen Organics is 3.1 while 3yr average is 8.02.

View FAQ's On Business

Growth Table

  • Medicamen Organics Ltd.
  • Omkar Pharmachem
  • Panjon

Balance Sheet

  • Medicamen Organics Ltd.
  • Omkar Pharmachem
  • Panjon

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Medicamen Organics Ltd.
  • Omkar Pharmachem
  • Panjon

Cash Flow

  • Medicamen Organics Ltd.
  • Omkar Pharmachem
  • Panjon

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Medicamen Organics Ltd.
  • Omkar Pharmachem
  • Panjon

Quarterly Results

  • Medicamen Organics Ltd.
  • Omkar Pharmachem
  • Panjon

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Medicamen Organics Ltd. Financials

Balance sheet of Medicamen Organics is moderately strong.

Yes, The net debt of Medicamen Organics is increasing.
Latest net debt of Medicamen Organics is ₹12.76 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹4.49 Crs.

Yes, profit is increasing.
The profit of Medicamen Organics is ₹4.57 Crs for TTM, ₹4.05 Crs for Mar 2025 and ₹2.62 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Medicamen Organics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech